27.07.2023 - DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2023. Second Quarter 2023 Financial Highlights: Revenue grew 25% versus the same quarter of the prior year to $871.3 million on a reported .
Medical device maker Dexcom Inc
on Thursday raised its annual revenue forecast after
strong demand for its continuous glucose monitoring
systems boosted second-quarter results, lifting its shares.